An analysis comparing drug-eluting vs bare-metal stents shows that drug-eluting stents reduce the risk for repeated procedures without increasing the risk for death or myocardial infarction. Medscape Medical News
New recommendations on antithrombotic and thrombolytic therapy from the American College of Chest Physicians have been published. Medscape Medical News
Madhav Rao, MD, and George Bakris, MD, from the University of Chicago review data demonstrating the benefits of ACEIs or ARBs in slowing CKD progression in those with advanced proteinuric nephropathy. Medscape Nephrology
Could myeloid-related protein 8/14 be a useful biomarker of platelet and inflammatory disease activity in atherothrombosis? If so, could it be a novel target for therapy in ACS patients? American Heart Journal
That is, among a broad population with systolic heart failure; there were signs that the strategy might benefit patients with less-advanced disease. Heartwire
A new ONTARGET imaging study has shown no difference between ramipril, telmisartan, or the combination in the reduction of left ventricular mass. The MRI study, say investigators, closely parallels the main findings from ONTARGET, showing no clear advantage to combination therapy. Heartwire
